152 related articles for article (PubMed ID: 16803682)
1. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
[TBL] [Abstract][Full Text] [Related]
2. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
[TBL] [Abstract][Full Text] [Related]
3. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
[TBL] [Abstract][Full Text] [Related]
4. Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features.
Mohammadi G; Jamialahmadi K; Lary S; Ghaffarzadegan K
Pak J Biol Sci; 2011 Mar; 14(5):357-62. PubMed ID: 21874828
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country.
Shabbir A; Mirza T; Khalid AB; Qureshi MA; Asim SA
BMC Cancer; 2016 Nov; 16(1):855. PubMed ID: 27821098
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer.
Rossi HA; Liu Q; Banner B; Hsieh CC; Savas L; Savarese D
Cancer J; 2002; 8(3):268-75. PubMed ID: 12074327
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas.
Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
BMC Cancer; 2006 Feb; 6():46. PubMed ID: 16507107
[TBL] [Abstract][Full Text] [Related]
8. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor Receptor Expression of Colorectal Carcinoma in Nigerian Patients.
Lawan AI; Ogunbiyi JO
West Afr J Med; 2020; 37(2):100-105. PubMed ID: 32150626
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.
Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
Int J Oncol; 2006 Feb; 28(2):329-35. PubMed ID: 16391786
[TBL] [Abstract][Full Text] [Related]
11. Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?
Demir L; Yigit S; Sadullahoglu C; Akyol M; Cokmert S; Kucukzeybek Y; Alacacioglu A; Cakalagaoglu F; Tarhan MO
Asian Pac J Cancer Prev; 2014; 15(22):9739-45. PubMed ID: 25520097
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2.
Maurer CA; Friess H; Kretschmann B; Zimmermann A; Stauffer A; Baer HU; Korc M; Büchler MW
Hum Pathol; 1998 Aug; 29(8):771-7. PubMed ID: 9712416
[TBL] [Abstract][Full Text] [Related]
13. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
[TBL] [Abstract][Full Text] [Related]
14. EGFR, HER-2 and COX-2 levels in colorectal cancer.
Antonacopoulou AG; Tsamandas AC; Petsas T; Liava A; Scopa CD; Papavassiliou AG; Kalofonos HP
Histopathology; 2008 Dec; 53(6):698-706. PubMed ID: 19102009
[TBL] [Abstract][Full Text] [Related]
15. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
Kavanagh DO; Chambers G; O'Grady L; Barry KM; Waldron RP; Bennani F; Eustace PW; Tobbia I
BMC Cancer; 2009 Jan; 9():1. PubMed ID: 19118499
[TBL] [Abstract][Full Text] [Related]
16. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer.
Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases.
McKay JA; Murray LJ; Curran S; Ross VG; Clark C; Murray GI; Cassidy J; McLeod HL
Eur J Cancer; 2002 Nov; 38(17):2258-64. PubMed ID: 12441262
[TBL] [Abstract][Full Text] [Related]
18. EGFR expression in gallbladder carcinoma in North America.
Kaufman M; Mehrotra B; Limaye S; White S; Fuchs A; Lebowicz Y; Nissel-Horowitz S; Thomas A
Int J Med Sci; 2008 Sep; 5(5):285-91. PubMed ID: 18825277
[TBL] [Abstract][Full Text] [Related]
19. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
20. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.
Ueda S; Ogata S; Tsuda H; Kawarabayashi N; Kimura M; Sugiura Y; Tamai S; Matsubara O; Hatsuse K; Mochizuki H
Pancreas; 2004 Jul; 29(1):e1-8. PubMed ID: 15211117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]